Université Paris-Saclay (France),
AFPT-Le Club Phase 1/EUFEMED/Université Paris-Saclay course: “Pre-Clinical and Clinical Safety in Early Development Human Trials”
This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. The training of several days provides a concise overview on safety in Human Pharmacology / Translational Medicine spanning from non-clinical pharmacology and toxicology over first-in-man to proof-of-concept clinical trials.
SITE HENRI MOISSAN
17 avenue des Sciences
Organiser and responsible for the programme
Association Française de Pharmacologie Translationnelle – Le Club Phase 1
34, avenue des Champs-Elysées
Coordinator: Dr Henri Caplain, President AFPT-Club Phase 1 Association française de pharmacologie translationnelle
Course exclusively in English and in presential due to its interactive nature. Depending on the covid situation, some parts of the course could be performed on-line.
Minimum number of participants: 10